The latest publications, events, blogs & casestudies

Latest Publications

| See all publications
Targeted optical fluorescence imaging: a meta‑narrative review and future perspectives.
Schouw, H. M., Huisman, L. A., Janssen, Y. F., Slart, R. H. J. A., Borra, R. J. H., Willemsen, A. T. M., Brouwers, A. H., van Dijl, J. M., Dierckx, R. A., van Dam, G. M., Szymanski, W., Boersma, H. H., Kruijff, S. European Journal Of Nuclear Medicine And Molecular Imaging. doi: 10.1007/s00259-021-05504-y

Read more
Download publication
Personalized type 2 diabetes treatment in primary care: insights using real world data
Martina Ambrož - Personalized type 2 diabetes treatment in primary care: insights using real world data.
This thesis examines personalized treatment for individuals with type 2 diabetes (T2D) in primary care. We studied glycated hemoglobin A1c (HbA1c) and systolic blood pressure (SBP) levels at the start of glucose- and blood pressure-lowering medication between 2007 and 2020. Surprisingly, no significant differences were found based on age or frailty, highlighting a lack of personalized treatment. Another study revealed more hypotension-related adverse events in older patients, those with polypharmacy, and lower SBP levels, emphasizing the need for tailored approaches. Sex differences in medication prescribing were identified, with females less likely to receive certain medications. Females with T2D also showed age-specific variations in LDL cholesterol levels, suggesting the need for sex-specific treatment recommendations. Additionally, patients' willingness to engage in different treatments varied, with only half open to all options. These findings underscore the importance of personalized approaches in T2D treatment, requiring attention in clinical practice and future research.
Read more
Download publication

Latest Blogs

| See all blogs

FDA Accelerated Approval Program

Prof. Go van Dam, MD, PhD

ICH M3 R2 guidelines for exploratory studies

Anne-Fleur Verhaar, MD

Strong data for start-up and scale-up biotech investments

Ari Aminetzah, MBA

Informed Consent Form for research: ICF in clinical trials

Tessa Aminetzah

Latest case studies

| See all case studies
Casestudy View Casestudy
  • Client
  • Sponsor
  • Partner since
  • 2022